講演・口頭発表等 - 金兼　弘和

分割表示  432 件中 61 - 80 件目  ／  全件表示 >>

  1. Okamoto K, Okano T, Kumaki E, Tanaka E, Ono S, Wada T, Ohnishi H, Kato Z, Nunoi N, Imai K, Kanegane H, Mori M, Morio T.. A Case of Non-Pulmonary Sarcoidosis Due to Novel Hypomorphic Missense Mutation of NCF2. ESID 2017 2017.09.11 Edinburgh,UK

  2. Kanegane H. Recent advances in primary antibody immunodeficiency and immunoglobulin replacement therapy. 21th Congress of Chinese Pediatric Society 2016.10 Zhuhai, PRC

  3. Ono S, Okano T, Hoshino A, Yanagimachi M, Takagi M, Imai K, Morio T, Kanegane H. Hematopoietic　stem　cell　transplantation for XIAP deficiency. XLP-WAS 2016 Symposium-London 2016.09.26 London, UK

  4. Kanegane H, Hoshino A, Takashima T, Yeh T-W, Okano T, Yamashita M, Imai K, Morio T. . Selective dysregulation of Epstein Barr virus infection in hypomorphic ZAP70 mutation. XLP-WAS 2016 Symposium-London 2016.09.26 London, UK

  5. Okano T, Watanabe E, Takashima T, Nishikawa T, Kawano Y, Tomoda T, Tanaka-Kubota M, Miyamoto S, Yeh T, Yamashita M, Tanaka K, Mitusiki N, Ohara O, Takagi M, Imai K, Kanegane H, Morio T.. IGG1 Gammopathy in X-SCID Caused by Maternal T and B cell Engraftment. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Barcelona, Spain

  6. Rojavin M, Kanegane H, Borte H, Imai K, Hubsch A, Jolles S.. Analysis of Patient Treatment Satisfaction from Five Studies of HIZENTRA 20% Subcutaneous Immunoglobulin. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Barcelona, Spain

  7. Moriya K, Tanita K, Ohnishi H, Niizuma H, Rikiishi T, Nishikomori R, Ishige T, Imai K, Kanegane H, Sasahara Y, Arakawa H, Kure S, Morio T. I <kappa> B-α S32 Mutations Underly Ectodermal Dysplasia with Immunodeficiency Manifestations and Correlation with Immunological Parameters.. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Brcelona, Spain

  8. Jolles S, Rojavin M, Nelson Jr. R, Wasserman R.L, Borte M, Kanegane H, Imai K.. Efficacy and Safety of HIZENTRA in Patients with Primary Immunodeficiency in Japan, Europe, and the US. 17th Biennial Meeting of17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Barcelona, Spain

  9. Schwab C, Gabrysch A, Hoshino M, Slatter M, Hayakawa S, Schubert D, Klemann C, Frede N, Salzer U, Speckmann C, Freiberger T, Lorenz H.M, Hauck F, Klobuch S, Zeissig S, Leichtner A, Van de Veerdonk F, Elemnto O, Giulino-Roth L, Duckers G, Niehues T, Alsina L, Deya-Martinez A, Kanderiva V, Fronkova E, Price C, Patino V, Blumberg R, Yesim Kucuk Z, Seneviratne S, Kanariou M, Lougaris V, Albert M, Giese T, Litzman J, Ehl S, Okada S, Imai K, Dybedai I, Tasken K, Wolff D, Warnatz K, Hambleton S, Arkwright P, Cant A, Kanegane H, Grimbacher B.. The Clinical Spectrum and Treatment Options of 82 Individuals with CTLA-4Deficiency. 17th Biennial Meeting of the European Society for Immunodeficiency 2016.09.22 Barcelona, Spain

  10. Hoshino A, Okada S, Yoshida K, Nishida N, Yamashita M, Okano T, Tsumura M, Nishimura S, Sakata S, Takagi M, Imai K, Miyano S, Ogawa S, Kojima S, Nonoyama S, Morio T, Kanegane H. . Abnormal Hematopoiesis and Autoimmunity in Humans with Germline IKZF1 Mutations. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.22 Barcelona, Spain

  11. Mitsui-Sekinaka K, Imai K, Tsujita Y, Mitsuiki N, Asano T, Sekinaka Y, Kanegane H, Yoshida K, Miyano S, Kojima S, Ogawa S, Ohara O, Okada S, Kobayashi M, Takagi M, Morio T, Nonoyama S.. Activated PI3 Kinase Delta Syndrome (APDS)-Like Immunodeficiency Caused by PTEN Mutation. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.22 Barcelona, Spain

  12. Kanegane H. Immunoglobulin Replacement for Agammaglobulinemia – Intravenous or Subcutaneous?. ASPID Spring School 2016.05.01 HongKong

  13. Okano T, Imai K, Tsujita Y, Mitsuiki, Mitsui-Sekinaka K, Takashima T, Kanegane H, Nonoyma S. Broad Spectrum of Clinical Manifestations and Outcome of Hematopoietic Stem Cell Transplantation in Japanese Patients with Activated P13KD Syndrome Type1. ASPID Spring School 2016.05.01 Hong Kong

  14. Kanegane H. Use of Flow Cytometry in PID diagnosis.. APSID Spring School 2016.04.28 Hong Kong

  15. Mikhail Rojavin, Hirokazu Kanegane, Michael Borte, Imai k , Alphonse P. Hubsch, Helena Soop, Stephen R. Jolles. Pooled Analysis of Patient Treatment Satisfaction from Five Hizentra Studies. 2016 AAAAI ANNUAL MEETING 2016.03.04 Los Angeles

  16. Hirokazu Kanegane. XLP (X-linked lympho proliferative syndrome) and Epstein-Barr virus infection.. V Simpósio Internacional de Immunodeficiências Primárias—SIDEP, 5 2015.05.20

  17. Ogashiwa T, Kunisaki R, Yasuhara H, Tsuda S, Koh R, Yazawa K, Gotoh K, Kimura H, Sugita A, Mori M, Tanaka M, Kanegane H, Maeda S. Clinical, Morphological and Histological Features of X-linked Lymphoproliferative Syndrome Type 2 Enteritis Diagnosed in three Cases with Childhood Onset Inflammatory Bowel Disease. 10th Congress of ECCO - Inflammatory Bowel Diseases. 10th Congress of ECCO - Inflammatory Bowel Diseases 2015.02.18 Barcelona

  18. Kanegane H. Whole exome sequencing reveals atypical phenotype of X-linked lymphoproliferative syndrome.. A symposium for researchers and clinicians on XLP WAS 2014.11.03 London, UK

  19. Yang X, Nishida N, Hoshino A, Goi K, Kanzaki T, Yoshida K, Muramatsu H, Ogawa S, Kojima S, Kanegane H. X-linked dysgammaglobulinemia associated with somatically reverted memory T cells in a family with X-linked lymphoproliferative syndrome type 1. 16th Biennial Meeting of the European Society of Immunodeficiencies 2014.10 Prague, Czech Rep

  20. Hoshino A, Okuno Y, Migita M, Ban H, Yang X, Kiyokawa N, Kojima S, Ohara O, Kanegane H. B-precursor acute lymphoblastic leukemia in a patient with X-linked agammaglobulinemia. 16TH Biennial Meeting of the European Society of Immunodeficiencies 2014.10

< 前のページ - 次のページ >

このページの先頭へ▲